Investment Management of Virginia’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-10,902
| Closed | -$979K | – | 145 |
|
|
2020
Q1 | $979K | Sell |
10,902
-185
| -2% | -$16.6K | 0.3% | 94 |
|
|
2019
Q4 | $1.2M | Buy |
11,087
+2,380
| +27% | +$257K | 0.27% | 85 |
|
|
2019
Q3 | $853K | Buy |
8,707
+345
| +4% | +$33.8K | 0.21% | 100 |
|
|
2019
Q2 | $1.1M | Sell |
8,362
-8,442
| -50% | -$1.11M | 0.26% | 100 |
|
|
2019
Q1 | $2.27M | Buy |
16,804
+11,412
| +212% | +$1.54M | 0.27% | 101 |
|
|
2018
Q4 | $525K | Sell |
5,392
-3,013
| -36% | -$293K | 0.14% | 127 |
|
|
2018
Q3 | $1.17M | Sell |
8,405
-720
| -8% | -$100K | 0.25% | 101 |
|
|
2018
Q2 | $1.13M | Buy |
9,125
+3,895
| +74% | +$484K | 0.25% | 106 |
|
|
2018
Q1 | $583K | Buy |
5,230
+480
| +10% | +$53.5K | 0.14% | 126 |
|
|
2017
Q4 | $568K | Sell |
4,750
-10
| -0.2% | -$1.2K | 0.13% | 124 |
|
|
2017
Q3 | $668K | Buy |
+4,760
| New | +$668K | 0.16% | 120 |
|